🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of the Phase II CLGX818X2102 study is to assess the ant...
Status
Terminated
Location
Sarah Cannon Research Institute Onc Dept
Start Date
2013-11
Trial ID
NCT01820364
Treatments Being Tested
The phase 1b study is aimed at determining the pediatric recommended phase ...
Status
Withdrawn
Location
Lucile Packard Children's Hospital at Stanford University Medical Center
Start Date
2021-10-01
Trial ID
NCT05222165
Treatments Being Tested
Background: People with tumor-induced osteomalacia (TIO) have small tumors...
Status
Terminated
Location
National Institutes of Health Clinical Center
Start Date
2019-02-27
Trial ID
NCT03510455
Treatments Being Tested
The aim of this research is to see whether using a drug that blocks a prote...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-12-23
Trial ID
NCT04972253
Treatments Being Tested
The study will determine the maximum tolerated dose and thus the recommende...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-12-11
Trial ID
NCT01004224
Treatments Being Tested
This is a multi-center, open label, single arm phase II study evaluating BG...
Status
Terminated
Location
QED Investigative Site
Start Date
2014-07-23
Trial ID
NCT02150967
Treatments Being Tested
The purpose of the study is identify the dose(s) of infigratinib to use in ...
Status
Terminated
Location
Stanford University
Start Date
2020-10-13
Trial ID
NCT04504331
Treatments Being Tested
The purpose of this study is to study the activity and effects of BGJ398 on...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2016-01-06
Trial ID
NCT02657486
Treatments Being Tested
Infigratinib is an oral drug which selectively binds to fibroblast growth f...
Status
Unknown
Location
Beijing Cancer Hospital ( Department of Thoracic Oncology )
Start Date
2020-05-13
Trial ID
NCT05019794
Treatments Being Tested
This phase Ib trial studies the side effects of infigratinib before surgery...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2020-07-28
Trial ID
NCT04228042
Treatments Being Tested